Lewin, Jeremy <br/><br/>
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  10 2018 
 - 3007-3014 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2018.78.2292  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--administration & dosage<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Heterocyclic Compounds, 3-Ring--administration & dosage<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Young Adult